Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT5B | Q4FZB7 | 1/20 | 0.40 |
| ▸ | KMT5C | Q86Y97 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 5/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CRHBP | P24387 | 1/20 | 0.35 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3677454 | 0.87 | ALDH1A1 (0.40) | SMN1; SMN2MEN1KMT2AMAPTNPC1 | |
| SCHEMBL3673565 | 0.85 | NPC1 (0.37) | SMN1; SMN2MEN1KMT2AMAPTNPC1 | |
| SCHEMBL3674922 | 0.82 | ADORA1 (0.42) | SMN1; SMN2MEN1KMT2AMAPTNPC1 | |
| SCHEMBL3671142 | 0.82 | KDM4E (0.45) | SMN1; SMN2MEN1KMT2AMAPTNPC1 | |
| SCHEMBL3786467 | 0.71 | KMT5B (0.54) | KMT5BKMT5CSMN1; SMN2MEN1KMT2A | |
| SCHEMBL3677456 | 0.71 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2AMAPTNPC1CYP1A2 | |
| SCHEMBL31196551 | 0.70 | NPC1 (0.60) | KMT5BKMT5CMEN1KMT2AMAPT | |
| SCHEMBL3673571 | 0.69 | CYP1A2 (0.32) | MAPTCYP1A2MAPK1ALDH1A1 | |
| SCHEMBL3806267 | 0.68 | ALOX15 (0.34) | SMN1; SMN2MEN1KMT2AMAPTCYP1A2 | |
| Lithium SCHEMBL3806270 | 0.68 | ALOX15 (0.34) | SMN1; SMN2MEN1KMT2AMAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1966225-B1 | TRANSITION METAL COMPLEXES AND PREPARATION METHODS THEREOF | LG CHEMICAL LTD (KR) | 2013-12-25 | — | — | EP | disclosed |
| EP-1966223-B1 | CATALYST COMPOSITION COMPRISING GROUP 4 TRANSITION METAL COMPLEXES AND METHOD FOR PREPARING POLYOLEFINS USING THE SAME | LG CHEMICAL LTD (KR) | 2013-08-14 | — | — | EP | disclosed |
| US-7807762-B2 | Catalyst composition comprising Group 4 transition metal complexes and method for preparing polyolefins using the same | LG CHEM, LTD. (KR) | 2010-10-05 | — | — | US | disclosed |
| US-7678933-B2 | Transition metal complexes and preparation methods thereof | LG CHEM, LTD. (KR) | 2010-03-16 | — | — | US | disclosed |
| US-20090030221-A1 | Transition Metal Complexes and Preparation Methods Thereof | LG CHEM, LTD (KR) | 2009-01-29 | — | — | US | disclosed |
| US-20090005525-A1 | Catalyst Composition Comprising Group 4 Transition Metal Complexes and Method for Preparing Polyolefins Using the Same | LG CHEM , LTD. (KR) | 2009-01-01 | — | — | US | disclosed |
| EP-1966223-A1 | CATALYST COMPOSITION COMPRISING GROUP 4 TRANSITION METAL COMPLEXES AND METHOD FOR PREPARING POLYOLEFINS USING THE SAME | LG Chem. Ltd. (KR) | 2008-09-10 | — | — | EP | disclosed |
| EP-1966225-A1 | TRANSITION METAL COMPLEXES AND PREPARATION METHODS THEREOF | LG Chem, Ltd. (KR) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007078134-A1 | TRANSITION METAL COMPLEXES AND PREPARATION METHODS THEREOF | LG CHEM. LTD. (KR) | 2007-07-12 | — | — | WO | disclosed |
| WO-2007078133-A1 | CATALYST COMPOSITION COMPRISING GROUP 4 TRANSITION METAL COMPLEXES AND METHOD FOR PREPARING POLYOLEFINS USING THE SAME | LG CHEM. LTD. (KR) | 2007-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030221-A1 | Transition Metal Complexes and Preparation Methods Thereof | PICALM, TEC, PPIP5K2 | KMT5B 92/4885KMT5C 86/4885SMN1; SMN2 2681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.